virtual cryptocurrency Top Top stories

According to the weekly comprehensive price quotation and transaction information of the national carbon market, the comprehensive price quotation of the national carbon market this week is: the highest price is 102.03 yuan/ton, and the lowest price is 98.95 yuan/ton, and the closing price is 0.20% lower than last Friday. This week, the transaction volume of the listing agreement was 4,455,200 tons, with a turnover of 443,893,910.63 yuan; The volume of bulk agreement transactions was 35,748,795 tons, with a turnover of 353,449,4051.32 yuan. This week, the total turnover of the national carbon emission quota was 40,203,995 tons, with a total turnover of 397,877,961.95 yuan. From January 1 to December 13, 2024, the volume of carbon emission quota in the national carbon market was 169,736,665 tons, with a turnover of 162,864,7748.47 yuan. As of December 13, 2024, the cumulative turnover of carbon emission quotas in the national carbon market was 611,359,276 tons, with a cumulative turnover of 412,056,282,67.75 yuan. (National Carbon Trading)The closing price of the national carbon market rose by 0.84% compared with the previous day. Today, the comprehensive price of the national carbon market is: the opening price is 99.66 yuan/ton, the highest price is 101.74 yuan/ton, the lowest price is 98.95 yuan/ton, and the closing price is 100.74 yuan/ton, which is 0.84% higher than the previous day. The transaction volume of today's listing agreement is 464,194 tons, with a turnover of 46,118,764.87 yuan; The volume of bulk agreement transactions was 4,617,079 tons, with a turnover of 450,306,945.18 yuan. Today, the total turnover of the national carbon emission quota is 5081273 tons, with a total turnover of 496425710.05 yuan. From January 1 to December 13, 2024, the volume of carbon emission quota in the national carbon market was 169,736,665 tons, with a turnover of 162,864,7748.47 yuan. As of December 13, 2024, the cumulative turnover of carbon emission quotas in the national carbon market was 611,359,276 tons, with a cumulative turnover of 412,056,282,67.75 yuan. (National Carbon Trading)Zhejiang Securities Regulatory Bureau: issued a warning letter to Hangzhou Huayu Frequent Private Equity Fund Co., Ltd. On December 13, the website of Zhejiang Securities Regulatory Bureau issued a decision on taking measures to issue a warning letter to Hangzhou Huayu Frequent Private Equity Fund Co., Ltd. After investigation, the company has the following behaviors in carrying out private equity fund business: 1. There are irregularities in the appropriate materials of fund products managed by investors, and the company has not made further audit; Second, the risk control review process of related party transactions is not perfect. The above behavior violates the first paragraph of Article 4 of the Interim Measures for the Supervision and Administration of Private Investment Funds (Order No.105 of the CSRC). According to the provisions of Article 33 of the Interim Measures for the Supervision and Administration of Private Investment Funds, Zhejiang Securities Regulatory Bureau decided to issue a warning letter to the company and record it in the integrity file of the securities and futures market.

Borui Medicine: Carboprost injection is planned to win the bid for the national centralized drug procurement. Borui Medicine announced that in the tenth batch of national centralized drug procurement in which Borui Pharmaceutical, a wholly-owned subsidiary, participated, carboprost tromethamine injection is planned to win the bid. This product is mainly used for 13-20 weeks pregnant abortion and postpartum hemorrhage. The specification is 1 ml: 250μ g, and the proposed bid price is 16.96 yuan/piece. In the first year, the agreed purchase base is 220,400 pieces, which are mainly supplied to Henan, Hubei, Guangxi, Shaanxi, Gansu, Ningxia and other provinces. If the contract is finally selected and signed, it will help the product to quickly open the domestic market and enhance the market share and brand influence of the company. The product obtained the drug registration certificate in March 2024, and has not yet generated sales revenue.The Bank of France expects France's economy to grow at zero month-on-month in the fourth quarter. The Bank of France, BNP Paribas, recently released the results of its monthly economic survey, and it is expected that France's gross domestic product (GDP) will grow at zero month-on-month in the fourth quarter of this year. (Xinhua News Agency)Tianyu Co., Ltd.: The subsidiary company plans to select the tenth batch of national centralized drug procurement, and the wholly-owned subsidiary company Zhejiang Nuode Pharmaceutical Co., Ltd. plans to select the product of sitagliptin metformin tablets (II) and sitagliptin phosphate tablets to select the tenth batch of national centralized drug procurement organized by the National Drug Joint Procurement Office.

Pacific Securities: Goldwind Technology's performance is expected to achieve rapid growth, with the first "buy" rating. Pacific Securities Research Report pointed out that with the profit recovery of wind turbine business and the contribution of wind farm investment and development and wind power service business, Goldwind Technology's (002202.SZ) performance is expected to achieve rapid growth. The first coverage gives a "buy" rating. Goldwind Technology has ranked first in the domestic wind power market for 13 consecutive years since 2011; However, in recent years, under the strong competitive pressure of wind turbine enterprises after the second line, their market share has declined. In the future, with the increase of market concentration, Goldwind Technology, as a leader, is expected to increase its share. At the end of the third quarter of 2024, the company's external order volume was 41.38GW, and sufficient in-hand order volume supported its share increase.A picture to understand the 2024 Central Economic Work Conference. (Xinhua News Agency)Indian market regulator: issue a draft notice to solicit opinions from retail investors on algorithmic trading. Algorithm trading should be provided by securities brokers and approved by the stock exchange.